Sky High Fund

Sky High VC operates as a biotech-specialized investment fund, strategically identifying, funding, and empowering visionary entrepreneurs across the science and technology sectors. The firm focuses on propelling early-stage startups, leveraging its extensive network and deep expertise to transition innovative concepts into market-leading solutions. Its core capability lies in recognizing and nurturing high-potential ventures that promise significant advancements in fields like precision medicine and healthtech.

The firm was established in 2020, with its origins rooted in Buenos Aires, Argentina, reflecting a global outlook with a strong Latin American base. Gustavo Rapisardi serves as a General Partner, guiding the firm's strategic direction and investment thesis. The foundational insight behind Sky High VC stemmed from a commitment to support changemakers dedicated to redefining mankind through scientific and technological innovation.

Sky High VC primarily serves founders of early-stage science and technology companies poised for revolutionary breakthroughs. The firm's long-term vision is to actively shape a future transformed by pioneering entrepreneurs, driving advancements that significantly improve the world. It aims to achieve this by investing in and supporting approximately twenty key changemakers over the coming decade, fostering a portfolio of groundbreaking ventures.